Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh
Clin Mol Hepatol. 2014;20(2):192-203.   Published online 2014 Jun 30     DOI: https://doi.org/10.3350/cmh.2014.20.2.192
Citations to this article as recorded by Crossref logo
Living-Donor Liver Transplantation for a Large Hepatocellular Carcinoma in a Genetically Identical Twin Sister
Ger Koek, Sophia M. Schmitz, Jan Bednarsch, Daniel Heise, Thomas Longerich, Frank Bakers, Christian Trautwein, Tom Luedde, Tom Florian Ulmer, Ulf Peter Neumann
Zeitschrift für Gastroenterologie.2024; 62(01): 56.     CrossRef
Validation of Japanese indication criteria for deceased donor liver transplantation for hepatocellular carcinoma: Analysis of US national registry data
Yuki Bekki, Shinji Itoh, Takeo Toshima, Mototsugu Shimokawa, Tomoharu Yoshizumi
Hepatology Research.2024; 54(7): 695.     CrossRef
Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma
Zheyu Zhou, Qiaoyu Liu, Jinsong Liu, Wenwen Li, Shuya Cao, Jiawei Xu, Jun Chen, Xiaoliang Xu, Chaobo Chen
Heliyon.2024; 10(9): e30622.     CrossRef
Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT)
Umberto Cillo, Amedeo Carraro, Alfonso W. Avolio, Matteo Cescon, Fabrizio Di Benedetto, Valerio Giannelli, Paolo Magistri, Daniele Nicolini, Marco Vivarelli, Jacopo Lanari, Salvatore Agnes, Enzo Andorno, Umberto Baccarani, Lucio Caccamo, Michele Colledan,
Updates in Surgery.2024; 76(3): 725.     CrossRef
Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
Jan Lerut, Quirino Lai
Transplantation.2023; 107(7): 1434.     CrossRef
Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
Claire Durkin, Douglas E. Schaubel, Yuwen Xu, Nadim Mahmud, David E. Kaplan, Peter L. Abt, Therese Bittermann
Transplantation.2023; 107(7): 1524.     CrossRef
Impact of Hypothermic Oxygenated Machine Perfusion on Hepatocellular Carcinoma Recurrence after Liver Transplantation
Federica Rigo, Nicola De Stefano, Damiano Patrono, Victor De Donato, Ludovico Campi, Diana Turturica, Teresa Doria, Veronica Sciannameo, Paola Berchialla, Francesco Tandoi, Renato Romagnoli
Journal of Personalized Medicine.2023; 13(5): 703.     CrossRef
Immunosuppressive Medication Adherence in Patients With Hepatocellular Cancer Who Have Undergo Liver Transplantation: A Case Control Study
Sami Akbulut, Murat Tamer, Serdar Saritas, Ozlem Unal, Musap Akyuz, Selver Unsal, Zeynep Kucukakcali, Ertugrul Karabulut, Sertac Usta, Sezai Yilmaz
Transplantation Proceedings.2023; 55(5): 1231.     CrossRef
Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma
Hans‐Christian Pommergaard
APMIS.2023; 131(S146): 1.     CrossRef
Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation
Jenny Abrahamsson, Malin Sternby Eilard, Magnus Rizell, William Bennett, Fredrik Åberg
Scandinavian Journal of Gastroenterology.2022; 57(3): 325.     CrossRef
State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection
Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel
Liver International.2022; 42(2): 288.     CrossRef
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
Hae Lim Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Ho Joong Choi, Gun Hyung Na, Young Kyoung You, Il Young Park, Dong Goo Kim
Liver Transplantation.2022; 28(3): 397.     CrossRef
ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis
Dipesh Kumar Yadav, Yong Fei Hua, Xueli Bai, Jianying Lou, Risheng Que, Shunling Gao, Yun Zhang, Ji Wang, Qinfen Xie, Muhammad Ibrahim Alhadi Edoo, Vikram Kumar Chutturghoon, Tingbo Liang
Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
Mini-review. Liver transplantation for hepatocellular carcinoma
V. Visag-Castillo
Revista Médica del Hospital General de México.2018; 81(2): 97.     CrossRef
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
Seong Hee Kang, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon
Journal of Korean Medical Science.2018;[Epub]     CrossRef
Basiliximab application on liver recipients: a meta-analysis of randomized controlled trials
Guo-Qing Zhang, Cheng-Shuo Zhang, Ning Sun, Wu Lv, Bao-Min Chen, Jia-Lin Zhang
Hepatobiliary & Pancreatic Diseases International.2017; 16(2): 139.     CrossRef
Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis
Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg, Allan Rasmussen
Transplantation Reviews.2016; 30(3): 171.     CrossRef
Entwicklungen der Immunmodulation nach Transplantation im Hinblick auf De-novo-Malignome und Tumorrezidive
J. Mittler, H. Lang
Der Onkologe.2016; 22(7): 461.     CrossRef
Cause and effect: the etiology of pediatric hepatocellular carcinoma and the role for liver transplantation
Allison F. O'Neill, Douglas W. Hanto, Howard M. Katzenstein
Pediatric Transplantation.2016; 20(7): 878.     CrossRef
Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital
C. San Miguel, Y. Fundora, J. Triguero, K. Muffak, T. Villegas, A. Becerra, D. Garrote, J.A. Ferrón
Transplantation Proceedings.2015; 47(8): 2371.     CrossRef
A Retrospective Study to Compare the use of Tacrolimus and Cyclosporine in Combination with Adriamycin in Post-Transplant Liver Cancer Patients
Liangfeng Gu, Wei Jin, Liandi Kan, Xia Wang, Chunlei Shan, Hui Fan
Cell Biochemistry and Biophysics.2015; 71(2): 565.     CrossRef
Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival
René Fahrner
World Journal of Gastroenterology.2015; 21(42): 12071.     CrossRef
Review on immunosuppression in liver transplantation
Maryam Moini
World Journal of Hepatology.2015; 7(10): 1355.     CrossRef
Glutamate Dehydrogenase and Alkaline Phosphatase as Very Early Predictors of Hepatocellular Carcinoma Recurrence after Liver Transplantation
Katja Piras-Straub, Khaleda Khairzada, Guido Gerken, Fuat Saner, Jürgen Treckmann, Andreas Paul, Ali Canbay, Kerstin Herzer
Digestion.2015; 91(2): 117.     CrossRef